Actionable insights — ServiceNow (NOW) 2Q26 preview
The repeatable analysis behind the call: not what the target is, but how a sell-side setup is read — written so the method can be rerun on the next software print.
How to read this page: each insight is a method — the diagnostic Goldman ran to size the setup and the multiple, and the signal to watch when re-running it on another name. The boxed line shows how it played out for ServiceNow this quarter.
1. Read the guide against trailing actuals — and price the conservatism in it
The repeatable method
- Put the forward guide next to the most recent actual for the same metric (here cRPO: 2Q guided ~17.25% organic vs 1Q actual ~20.0%) — the size of the implied deceleration is the real message, not the headline number.
- Ask why the guide stepped down. If the cut reflects added prudence after a one-off (Middle-East deal slippage, ~75bps hit to 1Q subscription growth) rather than eroding demand, the bar has been set low on purpose.
- Anchor the beat to history: compare the required beat to the multi-quarter average. A ~150bps cRPO beat matching the 3-year average, or a ~100bps subscription beat matching the prior 8 quarters, is a "normal" beat — not a stretch.
- Conclude on setup, not direction: a conservatively-set guide + an average-sized beat = a favorable print without needing a blowout.
Here: NOW guided 2Q organic cRPO to ~17.25% (vs ~20.0% 1Q) with Middle-East conservatism layered in, so Goldman's upside case (20.5–21.5% cRPO, 22–22.5% subscription) is just an average-magnitude beat against a lowered bar.
Watch for
- Any guide that decelerates sharply on a nameable one-off; then check whether the implied beat is merely in line with the trailing-average beat before calling the setup attractive.
2. Strip the acquired growth to judge the core
The repeatable method
- For any serial acquirer, decompose headline growth into organic vs. inorganic before comparing quarters — acquisitions inflate the reported number and mask the trend that actually re-rates the stock.
- Quantify each deal's contribution in basis points (here: Moveworks ~100bps, Armis ~125bps, Veza+Pyramid <50bps) and subtract to recover the organic line.
- Track the organic deceleration rate across years, not the level — management guiding ~200bps of core deceleration vs 300/300/200bps prior is the "stabilization" signal that carries the thesis.
- Treat M&A quality separately: distinguish gap-filling deals from position-of-weakness deals, and size tuck-ins (ai.work "in the tens of millions") so they don't distort the read.
Here: Goldman backs out ~225bps+ of acquired contribution from NOW's 19.5% headline cRPO guide to isolate ~17.25% organic, then judges the company's health on whether that organic line stabilizes.
Watch for
- Headline growth held up by recently-closed deals while the stripped-out organic rate quietly slides — the tell that a "growth" story is really an M&A story.
3. Name the single re-rating driver, then track its specific proof points
The repeatable method
- Reduce the multiple debate to one binary question the market is actually pricing (here: is ServiceNow relevant in the enterprise-AI stack, or disrupted by it?).
- Pre-commit to the concrete evidence that would answer it — Goldman names two: organic-revenue stabilization, and the analyst having to raise whole-company revenue estimates over time.
- Separate valuable growth from vanity growth: an AI-ACV target rising while total-revenue guidance is held forces the question of net-new budget vs. reallocation — weigh the composition (deeper workflow penetration, data gravity) not just the number.
- Let the driver flow to the multiple: the price-target cut here is a comps-driven de-rating (30x→27x), explicitly separated from the unchanged business call — so the re-rating catalyst is the proof points landing, not estimate tweaks.
Here: Goldman keeps Buy on NOW but cuts the target to $145 on lower comps, while pinning the re-rate to whether AI use cases (ITSM Level-1 automation, <100-day ROI, NVDA/FDX/CVS customers) convert into stabilizing organic revenue and upward WholeCo revisions.
Watch for
- A stock whose multiple hinges on a single unproven question; define in advance the one or two data series that would settle it, and watch those rather than the quarterly noise.
Methods distilled from a proprietary Goldman Sachs Global Investment Research note (PDF linked above), for personal study. Not investment advice. Source material © Goldman Sachs Global Investment Research.